International Clinical Trial: Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07293260) titled 'Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial' on Dec. 17, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Amgen

Condition: Cardiovascular Disease

Intervention: Drug: Olpasiran

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: March 21, 2026

Target Sample Size: 406

To know more, visit https://clinicaltrials.gov/study/NCT07293260

Published by HT Digital...